Skip to main content

Pacing and Defibrillation for Atrial Arrhythmias

  • Chapter
  • First Online:
Device Therapy in Heart Failure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 858 Accesses

Abstract

Atrial arrhythmias and heart failure frequently coexist. A number of device-based therapies are available for the diagnosis, prevention, and treatment of these arrhythmias. This chapter reviews the clinical impact of atrial and ventricular pacing on atrial arrhythmias, the diagnosis of atrial arrhythmias via device-based data retrieval, the value of alternate site atrial pacing algorithms for prevention of atrial fibrillation, and the treatment of atrial arrhythmias with device-based pacing and defibrillation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stangl K, Seitz K, Wirtzfeld A, Alt E, Blomer H. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1990;13:2080–5.

    Article  CAS  PubMed  Google Scholar 

  2. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992;19:1542–9.

    Article  CAS  PubMed  Google Scholar 

  3. Sgarbossa EB, Pinski SL, Maloney JD, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: relevance of clinical characteristics and pacing modalities. Circulation 1993;88:1045–53.

    CAS  PubMed  Google Scholar 

  4. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PEB. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523–8.

    Article  CAS  PubMed  Google Scholar 

  5. Andersen HR, Nielsen JC, Thomsen PEB, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210–6.

    Article  CAS  PubMed  Google Scholar 

  6. Gillis AM, Wyse DG, Connolly SJ, et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553–8.

    CAS  PubMed  Google Scholar 

  7. Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. Circulation 2000;102:736–41.

    CAS  PubMed  Google Scholar 

  8. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385–91.

    Article  CAS  PubMed  Google Scholar 

  9. Skanes AC, Krahn AD, Yee R, et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001;38:167–72.

    Article  CAS  PubMed  Google Scholar 

  10. Lamas GA, Orav J, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998;338:1097–104.

    Article  CAS  PubMed  Google Scholar 

  11. Wharton JM, Sorrentino RA, Campbell P, et al. Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardia–bradycardia syndrome: preliminary results of the Pacemaker Atrial Tachycardia Trial. Circulation 1998;98:I-494. Abstract.

    Google Scholar 

  12. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854–62.

    Article  PubMed  Google Scholar 

  13. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145–55.

    Article  CAS  PubMed  Google Scholar 

  14. Charles RG, McComb JM. Systematic trial of pacing to prevent atrial fibrillation (STOP-AF). Heart 1997;78:224–5.

    CAS  PubMed  Google Scholar 

  15. Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular-based pacing: Meta-analysis of randomized trials, using individual patient data. Circulation 2006;114:11–7.

    Article  PubMed  Google Scholar 

  16. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932–7.

    Article  PubMed  Google Scholar 

  17. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. J Am Med Assoc 2002;288:3115–23.

    Article  Google Scholar 

  18. Sweeney MO, Ellenbogen KA, Miller EH, et al. The managed ventricular pacing versus VVI 40 pacing (MVP) trial: clinical background, rationale, design, and implementation. J Cardiovasc Electrophysiol 2006;17:1295–8.

    Article  PubMed  Google Scholar 

  19. Olshansky B, Day JD, Moore S, et al. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing with AVSH in ICDs) study. Circulation 2007;115:9–16.

    Article  PubMed  Google Scholar 

  20. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA. Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. N Engl J Med 2007 Sep 6;357(1):1000–8.

    Article  CAS  PubMed  Google Scholar 

  21. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol 2008;51:e1–62

    Article  PubMed  Google Scholar 

  22. Seidl K, Meisel E, VanAgt E, et al. Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias? Pacing Clin Electrophysiol 1998;21:694–700.

    Article  CAS  PubMed  Google Scholar 

  23. Pollak WM, Simmons JD, Interian A Jr, et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 2001;24:424–9.

    Article  CAS  PubMed  Google Scholar 

  24. Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. Pacing Clin Electrophysiol 1998;21:250–5.

    Article  CAS  PubMed  Google Scholar 

  25. Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol 2002;13:542–7.

    Article  PubMed  Google Scholar 

  26. Orlov MV, Ghali JK, Araghi-Niknam M, et al., for the Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the Atrial High Rate Trial. Pacing Clin Electrophysiol 2007;30:404–11.

    Article  PubMed  Google Scholar 

  27. Glotzer TV, Hellkamp AS, Zimmerman J, et al., for the MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the Mode Selection Trial (MOST). Circulation 2003;107:1614–9.

    Article  PubMed  Google Scholar 

  28. Hohnloser SH, Capucci A, Fain E, et al. Asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial (ASSERT). Am Heart J 2006;152:442–7.

    Article  PubMed  Google Scholar 

  29. Ramdat Misier AR, Opthof T, van Hemel NM, et al. Increased dispersion of “refractoriness” in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 1992;19:1531–5.

    Article  Google Scholar 

  30. Spencer WH 3rd, Zhu DW, Markowitz T, Badruddin SM, Zoghbi WA. Atrial septal pacing: a method for pacing both atria simultaneously. Pacing Clin Electrophysiol 1997;20:2739–45.

    Article  PubMed  Google Scholar 

  31. Katsivas A, Manolis AG, Lazaris E, Vassilopoulos C, Louvros N. Atrial septal pacing to synchronize atrial depolarization in patients with delayed interatrial conduction. Pacing Clin Electrophysiol 1998;21:2220–5.

    Article  CAS  PubMed  Google Scholar 

  32. Rothinger FX, Abou-Harb M, Pachinger O, Hintringer F. The effect of the atrial pacing site on the total atrial activation time. Pacing Clin Electrophysiol 2001;24:316–22.

    Article  Google Scholar 

  33. Papageorgiou P, Anselme F, Kirchhof CJ, et al. Coronary sinus pacing prevents induction of atrial fibrillation. Circulation 1997;96:1893–8.

    CAS  PubMed  Google Scholar 

  34. Duytschaever M, Danse P, Eysbouts S, Allessie M. Is there an optimal pacing site to prevent atrial fibrillation?: an experimental study in the chronically instrumented goat. J Cardiovasc Electrophysiol 2002;13:1264–71.

    Article  PubMed  Google Scholar 

  35. Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001;12:912–7.

    Article  CAS  PubMed  Google Scholar 

  36. Padeletti L, Pieragnoli P, Ciapetti C, et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142: 1047–55.

    Article  CAS  PubMed  Google Scholar 

  37. Prakash A, Delfaut P, Krol RB, Saksena S. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol 1998;82:1197–1204.

    Article  CAS  PubMed  Google Scholar 

  38. Gilligan DM, Fuller IA, Clemo HF, et al. The acute effects of biatrial pacing on atrial depolarization and repolarization. Pacing Clin Electrophysiol 2000;23:1113–20.

    Article  CAS  PubMed  Google Scholar 

  39. Mirza I, Holt P, James S. Permanent left atrial pacing: a 2-year follow-up of coronary sinus leads. Pacing Clin Electrophysiol 2004;27:314–7.

    Article  PubMed  Google Scholar 

  40. Ouali S, Anselme F, Hidden F, et al. Effective long-term left atrial pacing using regular screw-in lead implanted within the coronary sinus. Pacing Clin Electrophysiol 2003;26:1873–7.

    Article  PubMed  Google Scholar 

  41. Levy T, Walker S, Rex S, Paul V. A comparison between passive and active fixation leads in the coronary sinus for biatrial pacing: initial experience. Europace 2000;2: 228–32.

    Article  CAS  PubMed  Google Scholar 

  42. Mirza I, James S, Holt P. Biatrial pacing for paroxysmal atrial fibrillation: a randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. J Am Coll Cardiol 2002;40:457–63.

    Article  PubMed  Google Scholar 

  43. Saksena S, Prakash A, Ziegler P, et al., for the DAPPAF Investigators. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002;40:1140–50.

    Article  PubMed  Google Scholar 

  44. Ellenbogen K. Pacing therapy for prevention of atrial fibrillation. Heart Rhythm 2007;4(Suppl 1):S84–7.

    Article  PubMed  Google Scholar 

  45. Knight BP, Gersh BJ, Carlson MD, et al., for the AHA Writing Group. Role of permanent pacing to prevent atrial fibrillation. Circulation 2005;111:240–3.

    Article  PubMed  Google Scholar 

  46. Defaye P, Dournaux F, Mouton E, et al., for the AIDA Multicenter Study Group. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. Pacing Clin Electrophysiol 1998;21:250–5.

    Article  CAS  PubMed  Google Scholar 

  47. Israel CW, Lawo T, Lemke B, Gronefeld G, Hohnloser SH. Atrial pacing in the prevention of paroxysmal atrial fibrillation: first results of a new combined algorithm. Pacing Clin Electrophysiol 2000;23:1888–90.

    Article  CAS  PubMed  Google Scholar 

  48. Funck RC, Adamec R, Lurje L, et al., on behalf of the PROVE Study Group. Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE study. Pacing Clin Electrophysiol 2000;23:1891–3.

    CAS  PubMed  Google Scholar 

  49. Carlson MD, Ip J, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627–33.

    Article  PubMed  Google Scholar 

  50. Hemels ME, Wiesfeld AC, Inberg B, et al. Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation. Europace 2006;8:107–12.

    Article  PubMed  Google Scholar 

  51. Lewalter T, Yang A, Pfeiffer D, et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin Electrophysiol 2006;29:124–34.

    Article  PubMed  Google Scholar 

  52. Blanc JJ, De Roy L, Mansourati J, et al., for the PIPAF Investigators. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 2004;6:371–9.

    Article  PubMed  Google Scholar 

  53. Schuchert A, Rebeski HP, Peiffer T, Bub E, Dietz A, Mortensen K, Aydin MA, Camm J, Gazarek S, Meinertz T; 3:4 Study Group. Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients. Pacing Clin Electrophysiol 2008 Aug;31(8):929–34.

    Article  PubMed  Google Scholar 

  54. Konz KH, Danilovic D, Brachmann J, et al. The influence of concomitant drug therapy on the efficacy of atrial overdrive stimulation for prevention of atrial tachyarrhythmias. Pacing Clin Electrophysiol 2003;26:272–7.

    Article  PubMed  Google Scholar 

  55. Israel CW, Gronefeld G, Ehrlich JR, Hohnloser SH. Suppression of atrial tachyarrhythmias by pacing. J Cardiovasc Electrophysiol 2002;13:S31–9.

    PubMed  Google Scholar 

  56. Ricci RP, Boriani G, Grammatico A, Santini M. Optimization of pacing algorithms to prevent and treat supraventricular tachyarrhythmias. Pacing Clin Electrophysiol 2006;29:S61–72.

    Article  PubMed  Google Scholar 

  57. Lau CP, Tse HF, Yu CM, et al., for the NIPP-AF Investigators. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am J Cardiol 2001;88:371–5.

    Article  CAS  PubMed  Google Scholar 

  58. De Simone A, Senatore G, Donnici G, et al. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: the Stimolazione Atrial Dinamica Multisito (STADIM) Study. Pacing Clin Electrophysiol 2007;30:S71–4.

    PubMed  Google Scholar 

  59. Padeletti L, Purerfellner H, Adler SW, et al., for the Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:1189–95.

    Article  PubMed  Google Scholar 

  60. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995;92:1954–68.

    CAS  PubMed  Google Scholar 

  61. Israel CW, Hugl B, Unterberg C, et al., for the AT500 Verification Study Investigators. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121–8.

    Article  CAS  PubMed  Google Scholar 

  62. Lee MA, Weachter R, Pollack S, et al., for the ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926–32.

    Article  PubMed  Google Scholar 

  63. Gulizia M, Mangiameli S, Orazi S, et al., for the PITAGORA investigators. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device. Europace 2006;8:465–73.

    Article  PubMed  Google Scholar 

  64. Hugl B, Israel CW, Unterberg C, et al., for the AT500 Verification Study Investigators. Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden. Europace 2003;5:403–9.

    Article  CAS  PubMed  Google Scholar 

  65. Gillis AM, Unterberg-Buchwald C, Schmidinger H, et al., for the GEM III AT Worldwide Investigators. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653–9.

    Article  PubMed  Google Scholar 

  66. Hemels ME, Ruiter JH, Molhoek GP, Veeger NJ, Wiesfeld AC, Ranchor AV, van Trigt M, Pilmeyer A, Van Gelder IC; Features in AT500TM Study. Chances for patients with episodes of atrial tachyarrhythmia without bradycardia indication for pacing (FACET) investigators right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study. Europace 2008 Mar;10(3):306–13.

    Article  PubMed  Google Scholar 

  67. Jung W, Wolpert C, Esmailzadeh B, et al. Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Interv Card Electrophysiol 2000;4:S185–95.

    Article  Google Scholar 

  68. Geller JC, Reek S, Timmermans C, et al. Treatment of atrial fibrillation with an implantable atrial defibrillator – long term results. Eur Heart J 2003;24:2083–9.

    Article  PubMed  Google Scholar 

  69. Daoud EG, Timmermans C, Fellows C, et al., for the METRIX Investigators. Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Circulation 2000;102:1407–13.

    CAS  PubMed  Google Scholar 

  70. Boodhoo L, Mitchell A, Ujhelyi M, Sulke N. Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2). Pacing Clin Electrophysiol 2004;27:910–7.

    Article  PubMed  Google Scholar 

  71. Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005;16:384–90.

    Article  PubMed  Google Scholar 

  72. Newman DM, Dorian P, Paquette M, et al., for the Worldwide Jewel AF-Only Investigators. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J 2003;145; 841–6.

    Article  PubMed  Google Scholar 

  73. Schwartzman D, Musley SK, Swerdlow C, et al. Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol 2002;40:93–9.

    Article  PubMed  Google Scholar 

  74. Spurrell P, Mitchell A, Kamalvand K, et al. Does sinus rhythm beget sinus rhythm? Long-term follow-up of the patient activated atrial defibrillator. Pacing Clin Electrophysiol 2004;27:175–81.

    Article  PubMed  Google Scholar 

  75. Schwartzman D, Gold M, Quesada A, et al., for the Worldwide Jewel AF-Only Investigators. Serial evaluation of atrial tachyarrhythmia burden and frequency after implantation of a dual-chamber cardioverter-defibrillator. J Cardiovasc Electrophysiol 2005;16: 708–13.

    Article  PubMed  Google Scholar 

  76. Funck RC, Boriani G, Manolis AS, Püererfellner H, Mont L, Tukkie R, Pisapia A, Israel CW, Grovale N, Grammatico A, Padeletti L; MINERVA Study Group. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Am Heart J 2008 Sep 1;156(3):445–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cooper, J.M. (2010). Pacing and Defibrillation for Atrial Arrhythmias. In: Maisel, W. (eds) Device Therapy in Heart Failure. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-424-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-424-7_8

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-994-9

  • Online ISBN: 978-1-59745-424-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics